Evidence map›Paper›PMID 28831543›Full record

ArticleRheumatology international2017

A single recent injury is a potent risk factor for the development of accelerated knee osteoarthritis: data from the osteoarthritis initiative.

Julie E Davis, Lori Lyn Price, Grace H Lo, Charles B Eaton, Timothy E McAlindon, Bing Lu, Mary F Barbe, Jeffrey B Driban

Open access · greenAbstract read
In one paragraph

Article in Rheumatology international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Accelerated knee osteoarthritis: a case description and literature analysis.Quantitative imaging in medicine and surgery · 2025
    Article
  2. Article
  3. Advances in the study of mitophagy in osteoarthritis.Journal of Zhejiang University. Science. B · 2024
    Article
  4. Synovial inflammation in osteoarthritis progression.Nature reviews. Rheumatology · 2022
    Review
  5. Epidemiology of osteoarthritis.Osteoarthritis and cartilage · 2022
    Review
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Julie E DavisDivision of Rheumatology, Tufts Medical Center, 800 Washington Street, Box 406, Boston, MA, 02111, USA.
Lori Lyn PriceThe Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.
Grace H LoMedical Care Line and Research Care Line, Houston Health Services Research and Development (HSR&D) Center of Excellence Michael E. DeBakey VAMC, Houston, TX, USA.
Charles B EatonCenter for Primary Care and Prevention, Alpert Medical School of Brown University, Pawtucket, RI, USA.
Timothy E McAlindonDivision of Rheumatology, Tufts Medical Center, 800 Washington Street, Box 406, Boston, MA, 02111, USA.
Bing LuDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Mary F BarbeDepartment of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, PA, USA.
Jeffrey B DribanDivision of Rheumatology, Tufts Medical Center, 800 Washington Street, Box 406, Boston, MA, 02111, USA. jeffrey.driban@tufts.edu.ORCID http://orcid.org/0000-0001-6098-4273
Tufts Medical Center · USBrigham and Women's Hospital · USBrown University · USMichael E. DeBakey VA Medical Center · USTemple University · USTufts University · US

Funding

Characterization of Rapidly Progressive Knee OsteoarthritisR01AR065977 · NIAMS · TUFTS MEDICAL CENTER · PI DRIBAN, JEFFREY B · 2015 to 2018
$1.5M
Modifiable Risk Factors for Incident and Progressive Early Knee OsteoarthritisK23AR062127 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI LO, GRACE · 2012 to 2016
$676k
National Institute of Arthritis and Musculoskeletal and Skin Diseases R01-AR065977NIAMS NIH HHS K23 AR062127NIAMS NIH HHS R01 AR065977
6 · The paper itself

Abstract

We examined the association between previously reported modifiable risk factors for accelerated knee osteoarthritis (AKOA) at the Osteoarthritis Initiative's (OAI) baseline and 48-month visits among adults who develop AKOA between the 48- and 96-month visits. We conducted a case-control study using data from the OAI baseline to the 96-month visit. Participants had no radiographic knee osteoarthritis (KOA) in the index knee at OAI baseline and 48-month visits [Kellgren-Lawrence (KL) <2]. We classified 2 groups: (1) AKOA: >1 knee developed advance-stage KOA (KL = 3 or 4) between 48- and 96-month visits and (2) No KOA: no KOA and no change in radiographic severity bilaterally over 96 months. We used logistic regression models to evaluate the association between the outcome of AKOA (versus no KOA) and several modifiable risk factors collected at OAI baseline and 48-month visits [body mass index (BMI), systolic blood pressure, comorbidity score, and NSAID use]. We also explored a new injury from baseline to 48 months and from 48- to 96 months. Adults with greater baseline and 48-month BMI were more likely to develop AKOA. Injury was only associated with AKOA onset when it occurred within 4 years of developing AKOA [prior 2 years: odds ratio = 6.21; 95% confidence interval (CI) 3.40, 11.35; 2-4 years prior: odds ratio = 4.42, 95% CI 2.06, 9.50]. BMI may consistently predispose an adult to AKOA, but certain injuries are likely a catalyst for AKOA.

Indexed as

AdultAgedBody Mass IndexCase-Control StudiesDisease ProgressionFemaleHumansKnee InjuriesKnee JointMaleMiddle AgedOsteoarthritis, KneeRisk FactorsTime FactorsInjuryKneeOsteoarthritis

Identifiers

PMID28831543
PMCPMC5693623
OpenAlexW2748796154

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.